Korean J Anesthesiol Search

CLOSE


Korean Journal of Anesthesiology 1969;2(1):35-39.
DOI: https://doi.org/10.4097/kjae.1969.2.1.35   
Trimethaphan Camphorsulfonate in the Treatment of Shock.
Kunil Lee
Department of Anesthesiology, Seoul National University, College of Medicine, Seoul, Korea.
Abstract
Trimethaphan camphorsulfonate (Arfonad), in 0.1 per cent concentration, has been administered slowly by intravenous drip to 6 patients in shock and protracted vasoconstrictive states. Administration of Arfonad results in vasodilation and relative hypovolemia. Blood or plasma expander was required to avoid an unacceptable hypotension. All patients survived except one, in whom the cause of death was not related .in any way to the use of Arfonad. Importance of supplementing respiration with oxygen and monitoring central venous pressure has been stressed and the rational use of both vasoconstrictor and vasiodiator discussed. At times, vasodilation is desirable, at other times, it may best be avoided. It is suggested that Arfonad may have a place in the treatment of shock but if so, it should be used only when protracted vasoconstriction exists.
TOOLS
Share :
Facebook Twitter Linked In Line it
METRICS Graph View
  • 0 Crossref
  •    
  • 1,364 View
  • 1 Download


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                

Copyright © 2024 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next